UNAUDITED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Cash Flows from Operating Activities:
Net income (loss)	$ 3,181,072	$ (211,186)	$ (5,093,380)	$ (210,251)	$ 2,773,882	$ (5,466,059)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Gain from settlement of deferred underwriting commissions	(2,616,250)		0		(2,616,250)	0
Unrealized gain on investments held in Trust Account	(745,227)		(12,523)		(895,570)	(32,334)
Changes in operating assets and liabilities:
Prepaid expenses					217,897	(447,236)
Accounts payable					(106,005)	9,154
Accrued expenses					132,936	4,990,724
Due to related party					60,000	0
Net cash used in operating activities					(433,110)	(945,751)
Cash Flows from Investing Activities:
Cash deposited in Trust Account					0	(149,500,000)
Net cash used in investing activities					0	(149,500,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party					0	127,075
Repayment of note payable to related party					0	(161,216)
Proceeds received from initial public offering, gross					0	149,500,000
Proceeds received from private placement					0	4,990,000
Offering costs paid					(45,000)	(3,386,471)
Net cash (used in) provided by financing activities					(45,000)	151,069,388
Net change in cash					(478,110)	623,637
Cash - beginning of the period		$ 501,242		$ 0	501,242	0	$ 0
Cash - end of the period	$ 23,132		$ 623,637		23,132	623,637	$ 501,242
Supplemental disclosure of noncash investing and financing activities:
Issuance of Class B ordinary shares to Sponsor in exchange for payment of outstanding accounts payable balance					0	25,000
Offering costs included in prepaid expenses					0	2,000
Offering costs included in accrued expenses					0	70,000
Offering costs paid by related party under promissory note					0	22,925
Deferred underwriting commissions					$ 0	$ 5,232,500